RMD Articles, ResMed Inc. - From 07/05/24

Neogen Corporation (NASDAQ: NEOG) effectively progresses with its strategic growth pillars, placing the company well for future success. The A...

SAN DIEGO, July 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE:RMD, ASX: RMD)) today announced it plans to release financial and operational results ...

ResMed (NYSE:RMD) has outperformed the market over the past 15 years by 3.3% on an annualized basis producing an average annual return of 16.26%. C...

Laboratory Corporation of America Holdings (NYSE: LH), or Labcorp's, focused efforts in the high-growth areas position it for strong growth in ...

QIAGEN N.V. (NYSE: QGEN) recently lauded the new guidelines in the United States that recommend screening at-risk children of all ages for lat...

Charles River Laboratories' (NYSE: CRL) Research Models and Services (RMS) business continues to benefit from the Charles River Accelerator and...

Following three years of nonstop regulatory hassles, Illumina (NASDAQ: ILMN) finally gave up on GRAIL (NASDAQ: GRAL), leading to the successful com...

Abbott's (NYSE: ABT) diversified business portfolio is well-positioned to drive continued momentum in 2024. However, a challenging macroeconomi...

ResMed, Inc. (NYSE:RMD) stock is trading lower Monday after Eli Lilly and Company (NYSE:LLY) released data from a clinical trial in regards to the ...

U.S. stocks were mixed, with the Dow Jones index gaining around 300 points on Monday. Shares of ResMed Inc. (NYSE:RMD) fell sharply during Monday&#...